A proper MS diagnosis can only be made after obtaining imaging from the entire brain and understanding the clinical context.
Shared decision-making includes engaging patients, comparing treatments, and assessing patient values.
"[This drug] is so inexpensive that it can be prescribed immediately with no insurance issues and is affordable for many who have no insurance," Dr Metz said.
A variant in TNFSF13B, encoding the cytokine and drug target B-cell activating factor (BAFF), was associated with both multiple sclerosis and SLE.
Fifteen different classes of transcripts detected 4 circulating exosomal sequences within the miRNA category that were differentially expressed.
Over a 5-year follow-up, there was no correlation between 24-hour urine sodium levels and conversion to clinically definite MS.
Communication with a pharmacist may help improve treatment adherence in multiple sclerosis.
The post-hoc analysis sought to identify factors predictive of relapse and disability progression in people with MS enrolled in the TRANSFORMS study.
Researchers sought to determine whether treatment with ocrelizumab improved measures of cognitive function better than interferon beta 1-a.
Initial trials of teriflunomide have demonstrated low lymphocyte counts in patients with relapsing forms of MS.
In patients with MS, hand function often correlates with measures of quality of life.
Neurology Advisor Articles
- Growing Old Without Alzheimer's Pathology: What's the Secret?
- Minocycline May Slow Progression From Clinically Isolated Syndrome to Multiple Sclerosis
- Brain Inflammation Observed in Obsessive-Compulsive Disorder
- Extended-Release Amantadine Reduces Levodopa-Induced Dyskinesia in Parkinson's Disease
- Treating Post-Traumatic Headache After Concussion